A recent study conducted by PURE, the industry's premier benchmark for evaluating patient support programs (PSPs), has named the best-in-class PSPs across key therapeutic areas. These programs, designed to help patients with access, affordability, and adherence, were evaluated by healthcare professionals (HCPs) based on the ability to address patient needs throughout the treatment journey. Feedback from over 2,000 HCPs and their support teams shaped the selection of winners, with the programs being recognized for their effectiveness, accessibility, and overall merit in assisting patients.

The awardees for each therapeutic area are:

• Pfizer: Best-in-Class for Oncology, recognized for a strong field reimbursement team and ease of use
• AbbVie: Best-in-Class for Neurology, Rheumatology, and Gastroenterology, praised for an outstanding educational support
• Sanofi/Regeneron: Best-in-Class for Dermatology, highly rated for program awareness
• AstraZeneca: Best-in-Class for Respiratory, commended for strong field engagement

These programs were lauded for offering comprehensive support such as access to treatment, disease education, emotional support, and financial assistance, all of which contribute to improved patient experiences. 

This recognition highlights the pivotal role pharmaceutical companies play in ensuring that patients receive necessary support throughout their treatment. By offering resources like dedicated case managers, educational materials, and financial assistance, these programs enhance patient adherence to treatment and foster stronger relationships with HCPs and patients.

The PURE study evaluates key factors such as patient and HCP satisfaction, program utilization, and the evolving needs of PSPs. Led by Jens Kulstad, PURE captures the “voice of the customer” by gathering insights from both patients and healthcare professionals, ensuring that support programs are tailored to real-world needs.

Kulstad commented: "These results provide an insightful roadmap for the future of patient support programs. These leading companies are setting the bar by actively addressing the dynamic needs of patients and HCPs across therapeutic areas."

PURE is owned and powered by Nuvera, an Inizio Engage company, a management consulting firm specializing in patient experience. Known as "treatment experience architects," Nuvera accelerates the integration of human-centered design, technology, and operational excellence to drive better patient access, care, and outcomes.